Aptevo Therapeutics Inc (APVO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.41 +0.03 (+1.26%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.47 +0.06 (+2.49%) 16:44 ET
for Fri, Mar 14th, 2025
Fiscal Year End Date: 12/31
12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
Cash Flows From Operating Activities | |||||
Net Income | -40,448 | -53,689 | 6,973 | -112,415 | -59,317 |
Depreciation Amortization | 2,235 | 2,390 | 3,127 | 3,362 | 2,907 |
Income taxes - deferred | N/A | N/A | N/A | N/A | -1,361 |
Accounts receivable | N/A | -3,079 | -1,834 | 2,172 | 3,884 |
Accounts payable and accrued liabilities | -2,697 | 1,279 | 195 | 2,479 | -2,384 |
Other Working Capital | -2,191 | -3,251 | -4,496 | 13,630 | 4,209 |
Other Operating Activity | 718 | 4,928 | -45,538 | 53,910 | 3,302 |
Operating Cash Flow | $-42,383 | $-51,422 | $-41,573 | $-36,862 | $-48,760 |
Cash Flows From Investing Activities | |||||
PPE Investments | -153 | -976 | -1,402 | -2,512 | -1,527 |
Net Acquisitions | 4,250 | 65 | 59,763 | N/A | N/A |
Purchase Of Investment | N/A | -16,535 | -99,633 | -44,882 | 0 |
Sale Of Investment | N/A | 90,243 | 70,730 | N/A | N/A |
Investing Cash Flow | $4,097 | $72,797 | $29,458 | $-47,394 | $-1,527 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | N/A | N/A | 18,038 | 0 |
Debt Repayment | -137 | N/A | N/A | N/A | N/A |
Common Stock Issued | 20,344 | 623 | 442 | 38 | 0 |
Other Financing Activity | -58 | -1,410 | 19,092 | 71,219 | 51,331 |
Financing Cash Flow | $20,149 | $-787 | $19,534 | $89,295 | $51,331 |
Beginning Cash Position | 38,083 | 17,495 | 10,076 | 4,637 | 3,593 |
End Cash Position | 19,946 | 38,083 | 17,495 | 9,676 | 4,637 |
Net Cash Flow | $-18,137 | $20,588 | $7,419 | $5,039 | $1,044 |
Free Cash Flow | |||||
Operating Cash Flow | -42,383 | -51,422 | -41,573 | -36,862 | -48,760 |
Capital Expenditure | -153 | -976 | -1,402 | -2,512 | -1,527 |
Free Cash Flow | -42,536 | -52,398 | -42,975 | -39,374 | -50,287 |